Table 1 Correlation between FTO expression and clinicopathological characteristics in prostate cancer.

From: N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability

Prostate Adenocarcinoma

N

FTO-High

FTO-Low

Chi squire

p

17.65%(12)

82.35%(56)

Age

> 65

56

10

46

0.0096

0.9218

< =65

12

2

10

Clinical stage

3–4

62

12

50

1.410

0.2350

1–2

6

0

6

Primary tumor

T3–T4

62

12

50

1.410

0.2350

T1–T2

6

0

6

Gleason score

< =6

5

2

3

1.855

0.1731

> 6

63

10

53

  1. The χ2 test was used to test the association between categorical variables.
Back to article page